MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-09-2026
Becton, Dickinson and Company Interest Expense 2011-2026 | BDX
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 613 M | 528 M | 452 M | 398 M | 469 M | 528 M | 639 M | 706 M | 521 M | 388 M | 371 M | 135 M | 138 M | 135 M | 84 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 706 M | 84 M | 407 M |
Quarterly Interest Expense Becton, Dickinson and Company
| 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10 M | -33 M | -38 M | -16 M | -13 M | -2 M | -4 M | 17 M | 118 M | 102 M | - | 99 M | 97 M | 98 M | - | 115 M | 124 M | 118 M | 405 M | 135 M | 118 M | 136 M | 498 M | 156 M | 136 M | 171 M | 525 M | 182 M | 171 M | 158 M | 364 M | 184 M | 158 M | 95 M | 293 M | 97 M | 95 M | 97 M | 272 M | 105 M | 97 M | 76 M | 99 M | 33 M | 76 M | 34 M | 104 M | 35 M | 34 M | 35 M | 99.4 M | 34.8 M | 35 M | 29.4 M | 61.7 M | 22.2 M | 29.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 525 M | -38 M | 114 M |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
290 M | $ 21.74 | 1.85 % | $ 11.2 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-1 K | $ 11.29 | -8.21 % | $ 228 M | USA |
 |
ICU Medical
ICUI
|
93.3 M | $ 155.85 | 4.08 % | $ 3.84 B | USA |
 |
Alcon
ALC
|
192 M | $ 82.21 | -1.21 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
683 K | $ 32.79 | 1.27 % | $ 1.57 B | USA |
 |
electroCore
ECOR
|
6.3 M | $ 6.16 | -0.16 % | $ 34 K | USA |
 |
Harvard Bioscience
HBIO
|
-227 K | $ 0.58 | -0.56 % | $ 24.6 M | USA |
 |
LeMaitre Vascular
LMAT
|
205 K | $ 92.55 | 0.75 % | $ 2.08 B | USA |
 |
AngioDynamics
ANGO
|
4.94 M | $ 11.22 | 0.13 % | $ 458 M | USA |
 |
InfuSystem Holdings
INFU
|
1.4 M | $ 7.9 | - | $ 163 M | USA |
 |
The Cooper Companies
COO
|
-16.4 M | $ 84.11 | 0.51 % | $ 16.7 B | USA |
 |
Haemonetics Corporation
HAE
|
-9.75 M | $ 61.61 | 1.55 % | $ 3.1 B | USA |
 |
iRhythm Technologies
IRTC
|
5.44 M | $ 150.56 | -5.24 % | $ 4.82 B | USA |
 |
Isoray
ISR
|
2 K | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
13.6 M | $ 119.69 | 2.21 % | $ 5.8 B | USA |
 |
Repro Med Systems
KRMD
|
561 K | $ 4.72 | 0.64 % | $ 215 M | USA |
 |
OraSure Technologies
OSUR
|
-380 K | $ 2.76 | -2.47 % | $ 205 M | USA |
 |
Masimo Corporation
MASI
|
300 K | $ 175.38 | 0.03 % | $ 9.35 B | USA |
 |
Merit Medical Systems
MMSI
|
-711 K | $ 82.25 | 0.5 % | $ 4.79 B | USA |
 |
Microbot Medical
MBOT
|
2 K | $ 2.07 | -3.95 % | $ 21.1 M |  Israel |
 |
Nephros
NEPH
|
2 K | $ 4.14 | 6.43 % | $ 43 M | USA |
 |
Milestone Scientific
MLSS
|
60.3 K | $ 0.26 | -2.04 % | $ 20.7 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
12 M | $ 12.63 | 0.88 % | $ 2.57 B | USA |
 |
Envista Holdings Corporation
NVST
|
-2.3 M | $ 29.16 | 1.53 % | $ 4.9 B | USA |
 |
Pro-Dex
PDEX
|
533 K | $ 39.55 | 1.41 % | $ 130 M | USA |
 |
Pulse Biosciences
PLSE
|
-52 K | $ 21.98 | -12.38 % | $ 1.48 B | USA |
 |
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | USA |
 |
Stereotaxis
STXS
|
1.1 M | $ 2.08 | -0.24 % | $ 168 M | USA |
 |
Repligen Corporation
RGEN
|
8.12 M | $ 136.76 | -0.34 % | $ 7.62 M | USA |
 |
ResMed
RMD
|
3.2 M | $ 258.04 | 0.68 % | $ 37.7 B | USA |
 |
BioLife Solutions
BLFS
|
497 K | $ 23.17 | -0.26 % | $ 1.07 B | USA |
 |
STERIS plc
STE
|
8.4 M | $ 250.32 | -0.34 % | $ 24.7 B | USA |
 |
Retractable Technologies
RVP
|
227 K | $ 0.67 | -3.48 % | $ 20.1 M | USA |
 |
STAAR Surgical Company
STAA
|
815 K | $ 17.65 | -1.29 % | $ 867 M | USA |
 |
Teleflex Incorporated
TFX
|
57 M | $ 115.88 | 3.65 % | $ 5.43 B | USA |
 |
Utah Medical Products
UTMD
|
256 K | $ 67.96 | 2.09 % | $ 247 M | USA |
 |
West Pharmaceutical Services
WST
|
-1 M | $ 241.54 | -0.94 % | $ 17.5 B | USA |